Faron Pharma says evidence base building around its technology
Clever-1 is a cell surface receptor shown to control a certain form of immunity
Company
Faron Pharmaceuticals Limited
LON:FARN
Faron Pharmaceuticals is a global, clinical-stage biopharmaceutical company, focused on creating innovative cancer treatments that leverage the patient’s own immune system. The company’s lead asset bexmarilimab is currently being investigated in Phase I/II clinical trial as a potential therapy for patients with hematological cancers in combination with other standard treatments.
418 stories · page 15 of 21
Investments and investor services
Morrisons in the spotlight as discounters are seeing a slowdown
The supermarket is the likely standouts in Thursday's market diary.
Water Intelligence shares in positive territory after strong first half performance
A look at some of the top risers and fallers in London on Wednesday
Archive
Proactive news snapshot: Erris Resources, Faron Pharma, Chariot Oil & Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
Faron Pharma welcomes latest Clever-1 data
Clever-1 is a cell surface receptor shown to control cell-mediated immunity
FTSE 100 closes higher with pound volatile, as tobacco stocks fire up on FDA move
The UK blue chip index rose 34 points to 7,308 around 3.40pm
Archive
Heatwave may help or hurt sales at Wetherspoons, JD Sports, Primark and Dunelm
The week ahead includes annual results from Wetherspoons, Galliford Try and Dunelm along with interims from Morrisons and trading updates from AB Foods and Ashtead
Investments and investor services
Small cap movers: There's gold in them thar hills - but it's hard to get it out
This week's round-up looks at the unforgiving nature of the investing public
Angus Energy, Sirius Minerals and Great Western Mining among Wednesday's movers
A look at some of the top risers and fallers in London today
Archive
Proactive news snapshot: BigDish, InnovaDerma, Galantas Gold …
A glance at some of the day's highlights from the Proactive Investors newswire
Abzena technology used to enhance Faron Pharma's cancer drug
The company used its Composite Human Antibody platform to enhance the drug
Investments and investor services
FTSE 100 consolidates gains as sterling's woes continue
Sterling's fall was good news for the Footsie's many big dollar earners
Archive
Gordon Dadds shares move higher as it delivers solid full year results
A look at some of the top risers and fallers in London today
Archive
Proactive news snapshot: Synairgen, Faron Pharmaceuticals, Arc Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Faron Pharmaceuticals to file clinical trial application for Clevegen after successful study
“We are very encouraged to find out about the good safety profile of our wholly-owned asset Clevegen," said Faron Pharmaceuticals chief executive Dr Markku Jalkanen
FTSE 100 joins other European benchmarks to go lower as trade fears continue to dent sentiment
FTSE 250 closed also lower - just shy of 160 points lower at 20,684, while FTSE small cap market shed around 25 points
EQTEC surges on new €22mln contract win
Some of the main news-driven risers and fallers in London on Thursday afternoon...
Archive
Proactive news snapshot: UK Oil & Gas Investments, ValiRx, Kazera Global …
A glance at some of the day's highlights from the Proactive Investors newswire
Faron Pharmaceuticals garners some encouragement from phase III data; still searching for answers to key questions
It has discovered that a sub-group of patients with higher levels of certain bio-markers showed a reduced mortality rate and increased ventilator-free days
Investments and investor services
FTSE 100 closes higher as European Central Bank message cheers markets
The FTSE 100 has clawed back all of this morning's losses and some, while the ECB has unveiled plans to end its quantitative easing programme in December